Pennant (PNTG) EBITDA Margin (2018 - 2026)
Pennant posted quarterly EBITDA Margin of 6.98% for Q1 2026, up 5.0% year-on-year from 6.65% in Q1 2025, and up 1.84% on a QoQ basis from 6.85% in Q4 2025.
Pennant (PNTG) has 9 years of EBITDA Margin data on file, last reported at 6.98% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 5.0% year-over-year to 6.98%; the trailing twelve-month figure through Mar 2026 stood at 6.43% (down 11.0% YoY), and the FY2025 full-year result was 6.38%, up 1.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 6.98%, up from 6.85% in the prior quarter.
- Across five years, EBITDA Margin topped out at 7.09% in Q3 2022 and bottomed at 1.59% in Q2 2022.
- The 5-year median for EBITDA Margin is 6.1% (2022), against an average of 5.56%.
- The widest annual swing landed in 2022, when EBITDA Margin plunged 588 bps; it then surged 724 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 6.1% in 2022, then retreated by 0 bps to 6.08% in 2023, then decreased by 4 bps to 5.86% in 2024, then climbed by 17 bps to 6.85% in 2025, then grew by 2 bps to 6.98% in 2026.
- The last three EBITDA Margin figures came in at 6.98% (Q1 2026), 6.85% (Q4 2025), and 5.37% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 84.64 Bn | 87.02 Bn | 16.26 Bn | -2.96% |
| 2 | Tenet Healthcare | 15.22 Bn | 14.39 Bn | 4.41 Bn | 24.14% |
| 3 | Davita | 13.10 Bn | 13.96 Bn | 1.07 Bn | 14.11% |
| 4 | Encompass Health | 10.50 Bn | 11.12 Bn | 1.34 Bn | 3.76% |
| 5 | Ensign | 9.69 Bn | 9.09 Bn | 293.37 Mn | 8.99% |
| 6 | Universal Health Services | 8.92 Bn | 8.88 Bn | 3.21 Bn | 11.19% |
| 7 | Fresenius Medical Care AG | 7.31 Bn | 4.93 Bn | 22,843.10 Bn | 0.02% |
| 8 | Chemed | 5.83 Bn | 5.81 Bn | 215.76 Mn | 15.04% |
| 9 | Pacs | 5.76 Bn | 5.51 Bn | 345.96 Mn | 8.45% |
| 10 | Pennant | 1.19 Bn | 1.23 Bn | 52.70 Mn | 6.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.98% |
| Dec 31, 2025 | 6.85% |
| Sep 30, 2025 | 5.37% |
| Jun 30, 2025 | 6.27% |
| Mar 31, 2025 | 6.93% |
| Dec 31, 2024 | 5.86% |
| Sep 30, 2024 | 6.80% |
| Jun 30, 2024 | 6.54% |
| Mar 31, 2024 | 6.28% |
| Dec 31, 2023 | 6.08% |
| Sep 30, 2023 | 5.98% |
| Jun 30, 2023 | 5.65% |
| Mar 31, 2023 | 4.39% |
| Dec 31, 2022 | 6.10% |
| Sep 30, 2022 | 7.09% |
| Jun 30, 2022 | -1.59% |
| Mar 31, 2022 | 3.02% |
| Dec 31, 2021 | -0.86% |
| Sep 30, 2021 | 2.58% |
| Jun 30, 2021 | 4.29% |
| Mar 31, 2021 | 2.63% |
| Dec 31, 2020 | 4.94% |
| Sep 30, 2020 | 5.78% |
| Jun 30, 2020 | 7.84% |
| Mar 31, 2020 | 5.76% |
| Dec 31, 2019 | -0.49% |
| Sep 30, 2019 | 3.38% |
| Jun 30, 2019 | 5.14% |
| Mar 31, 2019 | 3.37% |
| Dec 31, 2018 | 6.26% |
| Sep 30, 2018 | 7.95% |